Loading…

93 AUTISM SPECTRUM DISORDERS IN BOYS WITH THE FRAGILE X PREMUTATION

PurposeIt is commonly believed that individuals with the premutation allele (55 to 200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene are clinically unaffected compared to those with full mutation alleles (≥200 repeats). This study reports on 15 probands, the first affected individua...

Full description

Saved in:
Bibliographic Details
Published in:Journal of investigative medicine 2005-01, Vol.53 (1), p.S93-S94
Main Authors: Farzin, F., Perry, H., Hessl, D., Loesch, D. Z., Cohen, J., Gane, L. W., Kradin, M., Hagerman, R. J.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S94
container_issue 1
container_start_page S93
container_title Journal of investigative medicine
container_volume 53
creator Farzin, F.
Perry, H.
Hessl, D.
Loesch, D. Z.
Cohen, J.
Gane, L. W.
Kradin, M.
Hagerman, R. J.
description PurposeIt is commonly believed that individuals with the premutation allele (55 to 200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene are clinically unaffected compared to those with full mutation alleles (≥200 repeats). This study reports on 15 probands, the first affected individual to present clinically and 12 nonprobands identified through pedigree analysis. We compare both premutation groups to 17 male siblings without the FMR1 mutation. Understanding the variability among individuals with the fragile X premutation is important in early identification of symptoms, proper diagnosis, and therapeutic intervention.MethodsThis preliminary study includes 27 males with the FMR1 premutation, ranging in age from 5 to 22 years (mean age=10). Fifteen of them are probands and 12 are nonprobands. Seventeen male siblings without the FMR1 mutation, ages 5 to 22 (mean age=10), were included as controls. Parents of child participants completed the Conners' Global Index-Parent Version (CGI) and the Social Communication Questionnaire (SCQ. For a number we have Full Scale IQ scores. In addition, parents reported on learning disabilities, social deficits, and therapies and medications used in treatment.SummaryMean SCQ and CGI scores of probands and nonprobands combined were significantly different (p≤0.05) compared to controls. Results show 94% of probands, 42% of nonprobands, and 18% of controls met criteria for ADHD as demonstrated by a score of 15 or greater on the CGI and based on DSM-IV criteria. Symptoms of ASD were confirmed by a score of 15 or greater on SCQ in 59% of probands, 17% of nonprobands, and none of controls. By DSM-IV criteria, 73% of probands, 17% of nonprobands, and none of controls are on the autism spectrum. 40% of probands and 17% of nonprobands had full autism and 33% of probands had PDDNOS, which is significantly different from our control population. Based on parent report, 87% of probands, 70% of nonprobands, and none of controls demonstrated poor eye contact.ConclusionOur results show that the majority of young boys who present with the premutation as well as those that do not present have autism spectrum disorders and ADHD. In addition, cognitive deficits and other behavior problems, including anxiety and poor eye contact are common. Therefore, it is important for clinicians to carry out DNA testing on all siblings of individuals identified with fragile X syndrome so children with the premutation can be identified, evaluated,
doi_str_mv 10.2310/6650.2005.00005.92
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1786935037</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4045624131</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1097-81a4810c6a876a0a7f0f0af4c67d71a63b5d6d231289be5eb5f5627557cfdc883</originalsourceid><addsrcrecordid>eNqNkM1OwzAQhC0EEqXwApwscU5ZO_XfMaRpa6ltqsQRcLKcH0tUlJaEHnh7EsoDcNmdw8yu5kPonsCEhgQeOWe9AmATgGEqeoFGRIAMJOXistcgScCYVNfoput2AJQzRUcoViGOCqPzNc63SWyyYo1nOk-zWZLlWG_wU_qa42dtltgsEzzPooVeJfgFb7NkXZjI6HRzi668e--au789RsU8MfEyWKULHUeroCSgRCCJm0oCFXdScAdOePDg_LTiohbE8bBkNa_7OlSqsmFNyTzjVDAmKl9XUoZj9HC-e2wPn6em-7K7w6n96F9aIiRXIYNQ9C56dlXtoevaxttj-7Z37bclYAdYdoBlB1j2F5ZVtA8F51C53_3H_wOGrGGC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1786935037</pqid></control><display><type>article</type><title>93 AUTISM SPECTRUM DISORDERS IN BOYS WITH THE FRAGILE X PREMUTATION</title><source>Criminology Collection</source><source>Social Science Premium Collection (Proquest) (PQ_SDU_P3)</source><creator>Farzin, F. ; Perry, H. ; Hessl, D. ; Loesch, D. Z. ; Cohen, J. ; Gane, L. W. ; Kradin, M. ; Hagerman, R. J.</creator><creatorcontrib>Farzin, F. ; Perry, H. ; Hessl, D. ; Loesch, D. Z. ; Cohen, J. ; Gane, L. W. ; Kradin, M. ; Hagerman, R. J.</creatorcontrib><description>PurposeIt is commonly believed that individuals with the premutation allele (55 to 200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene are clinically unaffected compared to those with full mutation alleles (≥200 repeats). This study reports on 15 probands, the first affected individual to present clinically and 12 nonprobands identified through pedigree analysis. We compare both premutation groups to 17 male siblings without the FMR1 mutation. Understanding the variability among individuals with the fragile X premutation is important in early identification of symptoms, proper diagnosis, and therapeutic intervention.MethodsThis preliminary study includes 27 males with the FMR1 premutation, ranging in age from 5 to 22 years (mean age=10). Fifteen of them are probands and 12 are nonprobands. Seventeen male siblings without the FMR1 mutation, ages 5 to 22 (mean age=10), were included as controls. Parents of child participants completed the Conners' Global Index-Parent Version (CGI) and the Social Communication Questionnaire (SCQ. For a number we have Full Scale IQ scores. In addition, parents reported on learning disabilities, social deficits, and therapies and medications used in treatment.SummaryMean SCQ and CGI scores of probands and nonprobands combined were significantly different (p≤0.05) compared to controls. Results show 94% of probands, 42% of nonprobands, and 18% of controls met criteria for ADHD as demonstrated by a score of 15 or greater on the CGI and based on DSM-IV criteria. Symptoms of ASD were confirmed by a score of 15 or greater on SCQ in 59% of probands, 17% of nonprobands, and none of controls. By DSM-IV criteria, 73% of probands, 17% of nonprobands, and none of controls are on the autism spectrum. 40% of probands and 17% of nonprobands had full autism and 33% of probands had PDDNOS, which is significantly different from our control population. Based on parent report, 87% of probands, 70% of nonprobands, and none of controls demonstrated poor eye contact.ConclusionOur results show that the majority of young boys who present with the premutation as well as those that do not present have autism spectrum disorders and ADHD. In addition, cognitive deficits and other behavior problems, including anxiety and poor eye contact are common. Therefore, it is important for clinicians to carry out DNA testing on all siblings of individuals identified with fragile X syndrome so children with the premutation can be identified, evaluated, and treated for these problems.</description><identifier>ISSN: 1081-5589</identifier><identifier>EISSN: 1708-8267</identifier><identifier>DOI: 10.2310/6650.2005.00005.92</identifier><language>eng</language><publisher>London: Sage Publications Ltd</publisher><ispartof>Journal of investigative medicine, 2005-01, Vol.53 (1), p.S93-S94</ispartof><rights>2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2015 (c) 2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1786935037/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1786935037?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21376,21394,27924,27925,33611,33769,43733,43814,74221,74310</link.rule.ids></links><search><creatorcontrib>Farzin, F.</creatorcontrib><creatorcontrib>Perry, H.</creatorcontrib><creatorcontrib>Hessl, D.</creatorcontrib><creatorcontrib>Loesch, D. Z.</creatorcontrib><creatorcontrib>Cohen, J.</creatorcontrib><creatorcontrib>Gane, L. W.</creatorcontrib><creatorcontrib>Kradin, M.</creatorcontrib><creatorcontrib>Hagerman, R. J.</creatorcontrib><title>93 AUTISM SPECTRUM DISORDERS IN BOYS WITH THE FRAGILE X PREMUTATION</title><title>Journal of investigative medicine</title><description>PurposeIt is commonly believed that individuals with the premutation allele (55 to 200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene are clinically unaffected compared to those with full mutation alleles (≥200 repeats). This study reports on 15 probands, the first affected individual to present clinically and 12 nonprobands identified through pedigree analysis. We compare both premutation groups to 17 male siblings without the FMR1 mutation. Understanding the variability among individuals with the fragile X premutation is important in early identification of symptoms, proper diagnosis, and therapeutic intervention.MethodsThis preliminary study includes 27 males with the FMR1 premutation, ranging in age from 5 to 22 years (mean age=10). Fifteen of them are probands and 12 are nonprobands. Seventeen male siblings without the FMR1 mutation, ages 5 to 22 (mean age=10), were included as controls. Parents of child participants completed the Conners' Global Index-Parent Version (CGI) and the Social Communication Questionnaire (SCQ. For a number we have Full Scale IQ scores. In addition, parents reported on learning disabilities, social deficits, and therapies and medications used in treatment.SummaryMean SCQ and CGI scores of probands and nonprobands combined were significantly different (p≤0.05) compared to controls. Results show 94% of probands, 42% of nonprobands, and 18% of controls met criteria for ADHD as demonstrated by a score of 15 or greater on the CGI and based on DSM-IV criteria. Symptoms of ASD were confirmed by a score of 15 or greater on SCQ in 59% of probands, 17% of nonprobands, and none of controls. By DSM-IV criteria, 73% of probands, 17% of nonprobands, and none of controls are on the autism spectrum. 40% of probands and 17% of nonprobands had full autism and 33% of probands had PDDNOS, which is significantly different from our control population. Based on parent report, 87% of probands, 70% of nonprobands, and none of controls demonstrated poor eye contact.ConclusionOur results show that the majority of young boys who present with the premutation as well as those that do not present have autism spectrum disorders and ADHD. In addition, cognitive deficits and other behavior problems, including anxiety and poor eye contact are common. Therefore, it is important for clinicians to carry out DNA testing on all siblings of individuals identified with fragile X syndrome so children with the premutation can be identified, evaluated, and treated for these problems.</description><issn>1081-5589</issn><issn>1708-8267</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>BGRYB</sourceid><sourceid>M0O</sourceid><recordid>eNqNkM1OwzAQhC0EEqXwApwscU5ZO_XfMaRpa6ltqsQRcLKcH0tUlJaEHnh7EsoDcNmdw8yu5kPonsCEhgQeOWe9AmATgGEqeoFGRIAMJOXistcgScCYVNfoput2AJQzRUcoViGOCqPzNc63SWyyYo1nOk-zWZLlWG_wU_qa42dtltgsEzzPooVeJfgFb7NkXZjI6HRzi668e--au789RsU8MfEyWKULHUeroCSgRCCJm0oCFXdScAdOePDg_LTiohbE8bBkNa_7OlSqsmFNyTzjVDAmKl9XUoZj9HC-e2wPn6em-7K7w6n96F9aIiRXIYNQ9C56dlXtoevaxttj-7Z37bclYAdYdoBlB1j2F5ZVtA8F51C53_3H_wOGrGGC</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Farzin, F.</creator><creator>Perry, H.</creator><creator>Hessl, D.</creator><creator>Loesch, D. Z.</creator><creator>Cohen, J.</creator><creator>Gane, L. W.</creator><creator>Kradin, M.</creator><creator>Hagerman, R. J.</creator><general>Sage Publications Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AM</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGRYB</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K7.</scope><scope>K9.</scope><scope>M0O</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>200501</creationdate><title>93 AUTISM SPECTRUM DISORDERS IN BOYS WITH THE FRAGILE X PREMUTATION</title><author>Farzin, F. ; Perry, H. ; Hessl, D. ; Loesch, D. Z. ; Cohen, J. ; Gane, L. W. ; Kradin, M. ; Hagerman, R. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1097-81a4810c6a876a0a7f0f0af4c67d71a63b5d6d231289be5eb5f5627557cfdc883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farzin, F.</creatorcontrib><creatorcontrib>Perry, H.</creatorcontrib><creatorcontrib>Hessl, D.</creatorcontrib><creatorcontrib>Loesch, D. Z.</creatorcontrib><creatorcontrib>Cohen, J.</creatorcontrib><creatorcontrib>Gane, L. W.</creatorcontrib><creatorcontrib>Kradin, M.</creatorcontrib><creatorcontrib>Hagerman, R. J.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Criminal Justice Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Criminology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Criminal Justice Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of investigative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farzin, F.</au><au>Perry, H.</au><au>Hessl, D.</au><au>Loesch, D. Z.</au><au>Cohen, J.</au><au>Gane, L. W.</au><au>Kradin, M.</au><au>Hagerman, R. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>93 AUTISM SPECTRUM DISORDERS IN BOYS WITH THE FRAGILE X PREMUTATION</atitle><jtitle>Journal of investigative medicine</jtitle><date>2005-01</date><risdate>2005</risdate><volume>53</volume><issue>1</issue><spage>S93</spage><epage>S94</epage><pages>S93-S94</pages><issn>1081-5589</issn><eissn>1708-8267</eissn><abstract>PurposeIt is commonly believed that individuals with the premutation allele (55 to 200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene are clinically unaffected compared to those with full mutation alleles (≥200 repeats). This study reports on 15 probands, the first affected individual to present clinically and 12 nonprobands identified through pedigree analysis. We compare both premutation groups to 17 male siblings without the FMR1 mutation. Understanding the variability among individuals with the fragile X premutation is important in early identification of symptoms, proper diagnosis, and therapeutic intervention.MethodsThis preliminary study includes 27 males with the FMR1 premutation, ranging in age from 5 to 22 years (mean age=10). Fifteen of them are probands and 12 are nonprobands. Seventeen male siblings without the FMR1 mutation, ages 5 to 22 (mean age=10), were included as controls. Parents of child participants completed the Conners' Global Index-Parent Version (CGI) and the Social Communication Questionnaire (SCQ. For a number we have Full Scale IQ scores. In addition, parents reported on learning disabilities, social deficits, and therapies and medications used in treatment.SummaryMean SCQ and CGI scores of probands and nonprobands combined were significantly different (p≤0.05) compared to controls. Results show 94% of probands, 42% of nonprobands, and 18% of controls met criteria for ADHD as demonstrated by a score of 15 or greater on the CGI and based on DSM-IV criteria. Symptoms of ASD were confirmed by a score of 15 or greater on SCQ in 59% of probands, 17% of nonprobands, and none of controls. By DSM-IV criteria, 73% of probands, 17% of nonprobands, and none of controls are on the autism spectrum. 40% of probands and 17% of nonprobands had full autism and 33% of probands had PDDNOS, which is significantly different from our control population. Based on parent report, 87% of probands, 70% of nonprobands, and none of controls demonstrated poor eye contact.ConclusionOur results show that the majority of young boys who present with the premutation as well as those that do not present have autism spectrum disorders and ADHD. In addition, cognitive deficits and other behavior problems, including anxiety and poor eye contact are common. Therefore, it is important for clinicians to carry out DNA testing on all siblings of individuals identified with fragile X syndrome so children with the premutation can be identified, evaluated, and treated for these problems.</abstract><cop>London</cop><pub>Sage Publications Ltd</pub><doi>10.2310/6650.2005.00005.92</doi></addata></record>
fulltext fulltext
identifier ISSN: 1081-5589
ispartof Journal of investigative medicine, 2005-01, Vol.53 (1), p.S93-S94
issn 1081-5589
1708-8267
language eng
recordid cdi_proquest_journals_1786935037
source Criminology Collection; Social Science Premium Collection (Proquest) (PQ_SDU_P3)
title 93 AUTISM SPECTRUM DISORDERS IN BOYS WITH THE FRAGILE X PREMUTATION
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A15%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=93%20AUTISM%20SPECTRUM%20DISORDERS%20IN%20BOYS%20WITH%20THE%20FRAGILE%20X%20PREMUTATION&rft.jtitle=Journal%20of%20investigative%20medicine&rft.au=Farzin,%20F.&rft.date=2005-01&rft.volume=53&rft.issue=1&rft.spage=S93&rft.epage=S94&rft.pages=S93-S94&rft.issn=1081-5589&rft.eissn=1708-8267&rft_id=info:doi/10.2310/6650.2005.00005.92&rft_dat=%3Cproquest_cross%3E4045624131%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b1097-81a4810c6a876a0a7f0f0af4c67d71a63b5d6d231289be5eb5f5627557cfdc883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1786935037&rft_id=info:pmid/&rfr_iscdi=true